Correlation Between Allena Pharmaceuticals and Icad

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Allena Pharmaceuticals and Icad at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allena Pharmaceuticals and Icad into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allena Pharmaceuticals and Icad Inc, you can compare the effects of market volatilities on Allena Pharmaceuticals and Icad and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allena Pharmaceuticals with a short position of Icad. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allena Pharmaceuticals and Icad.

Diversification Opportunities for Allena Pharmaceuticals and Icad

0.55
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Allena and Icad is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding Allena Pharmaceuticals and Icad Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icad Inc and Allena Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allena Pharmaceuticals are associated (or correlated) with Icad. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icad Inc has no effect on the direction of Allena Pharmaceuticals i.e., Allena Pharmaceuticals and Icad go up and down completely randomly.

Pair Corralation between Allena Pharmaceuticals and Icad

Given the investment horizon of 90 days Allena Pharmaceuticals is expected to under-perform the Icad. In addition to that, Allena Pharmaceuticals is 2.1 times more volatile than Icad Inc. It trades about -0.02 of its total potential returns per unit of risk. Icad Inc is currently generating about -0.03 per unit of volatility. If you would invest  1,057  in Icad Inc on May 12, 2022 and sell it today you would lose (675.00)  from holding Icad Inc or give up 63.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Allena Pharmaceuticals  vs.  Icad Inc

 Performance (%) 
       Timeline  
Allena Pharmaceuticals 
Allena Performance
4 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Allena Pharmaceuticals are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Allena Pharmaceuticals sustained solid returns over the last few months and may actually be approaching a breakup point.

Allena Price Channel

Icad Inc 
Icad Performance
3 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Icad Inc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Icad may actually be approaching a critical reversion point that can send shares even higher in September 2022.

Icad Price Channel

Allena Pharmaceuticals and Icad Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Allena Pharmaceuticals and Icad

The main advantage of trading using opposite Allena Pharmaceuticals and Icad positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allena Pharmaceuticals position performs unexpectedly, Icad can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icad will offset losses from the drop in Icad's long position.

Allena Pharmaceuticals

Pair trading matchups for Allena Pharmaceuticals

The idea behind Allena Pharmaceuticals and Icad Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go